We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
RP
26
Riverbridge Partners
Minnesota
$84M +$1.4M +10,153 +2%
Northern Trust
27
Northern Trust
Illinois
$83.4M -$311K -2,261 -0.4%
Wells Fargo
28
Wells Fargo
California
$78M +$16.2M +117,781 +27%
UIM
29
USS Investment Management
United Kingdom
$75.6M -$76.2M -553,558 -51%
Bank of America
30
Bank of America
North Carolina
$70.4M -$8.4M -61,017 -11%
N
31
Nuveen
North Carolina
$68.2M +$24.4M +176,994 +58%
Schroder Investment Management Group
32
Schroder Investment Management Group
United Kingdom
$61.3M -$17.8M -128,966 -23%
Prudential Financial
33
Prudential Financial
New Jersey
$59.7M +$156K +1,135 +0.3%
Charles Schwab
34
Charles Schwab
California
$58.9M +$2.06M +14,936 +4%
Ameriprise
35
Ameriprise
Minnesota
$54.1M +$8.34M +60,593 +19%
Renaissance Technologies
36
Renaissance Technologies
New York
$52.9M +$8.77M +63,700 +21%
GKIM
37
GW&K Investment Management
Massachusetts
$48.8M -$34.7K -252 -0.1%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$48.4M -$3.66M -26,577 -7%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$47.9M -$596K -4,327 -1%
Principal Financial Group
40
Principal Financial Group
Iowa
$45.8M -$739K -5,370 -2%
IIP
41
Intermede Investment Partners
United Kingdom
$41.9M -$493K -3,584 -1%
AQR Capital Management
42
AQR Capital Management
Connecticut
$35.4M +$3.37M +24,462 +11%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$34.9M -$448K -3,257 -1%
AAM
44
AMI Asset Management
California
$32.6M -$19.8M -143,651 -38%
Victory Capital Management
45
Victory Capital Management
Texas
$32.3M +$3.9M +28,330 +14%
Mawer Investment Management
46
Mawer Investment Management
Alberta, Canada
$31.9M -$9.87M -71,667 -24%
Morgan Stanley
47
Morgan Stanley
New York
$30M +$25.4M +184,407 +685%
SCM
48
Sterling Capital Management
North Carolina
$27.8M -$3.51M -25,500 -12%
PPA
49
Parametric Portfolio Associates
Washington
$26.6M +$477K +3,465 +2%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$25.3M +$6.51M +47,277 +36%
1
2
3 4 5

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.